Pancreatic Cancer Research

ResearcherQueen Mary University of LondonActive in the last 2 years

Louisa S. Chard Dunmall

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2380-0900; OpenAlex author ID A5060616522. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 9

  1. Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer. Co-author DOI 10.1136/jitc-2024-010341↗
  2. The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocom… Co-author DOI 10.3390/cancers17091534↗
  3. MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. Co-author DOI 10.1080/2162402x.2022.2080329↗
  4. A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer. First author DOI 10.1136/jitc-2020-001624↗
  5. Correction: A Virus-infected, Reprogrammed Somatic Cell-derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Can… Co-author DOI 10.1158/1078-0432.ccr-21-0850↗
  6. A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-1395↗
  7. Promising xenograft animal model recapitulating the features of human pancreatic cancer. Co-author DOI 10.3748/wjg.v26.i32.4802↗
  8. New role of Interleukin-10 in enhancing the antitumor efficacy of oncolytic vaccinia virus for treatment of pancreatic cancer. Co-author DOI 10.1080/2162402x.2015.1038689↗
  9. A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0464↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yaohe Wang · 9 shared papers, 2015–2025 · strength 1.14
  2. Renato B. Baleeiro · 2 shared papers, 2022–2025 · strength 0.40
  3. Claude Chelala · 3 shared papers, 2020–2022 · strength 0.32
  4. Lauren C. Cutmore · 1 shared paper, 2025 · strength 0.26
  5. Nicholas Fraser Brown · 1 shared paper, 2025 · strength 0.26
  6. Zuoyi Zhao · 1 shared paper, 2025 · strength 0.26
  7. John F. Marshall · 1 shared paper, 2025 · strength 0.26
  8. Jinxin Miao · 2 shared papers, 2020–2021 · strength 0.23
  9. Pengju Wang · 1 shared paper, 2025 · strength 0.22
  10. Wenyi Yan · 1 shared paper, 2025 · strength 0.22
  11. Yangyang Jia · 1 shared paper, 2025 · strength 0.22
  12. Shuangshuang Lu · 2 shared papers, 2020–2021 · strength 0.17
  13. Jun Wang · 2 shared papers, 2020–2021 · strength 0.17
  14. Hemant Mahendrakumar Kocher · 1 shared paper, 2022 · strength 0.15
  15. Giulia Marelli · 1 shared paper, 2021 · strength 0.12
  16. Zhe Zhang · 1 shared paper, 2021 · strength 0.09
  17. Eleni Maniati · 1 shared paper, 2015 · strength 0.04
  18. Pengju Wang · 1 shared paper, 2015 · strength 0.04
  19. Thorsten Hagemann · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.